Salama Mahmoud, Isachenko Vladimir, Isachenko Evgenia, Rahimi Gohar, Mallmann Peter
Department of Gynecology and Obstetrics, Medical Faculty, University of Cologne, Germany; Department of Reproductive Medicine, Medical Division, National Research Center of Egypt, Egypt.
Department of Gynecology and Obstetrics, Medical Faculty, University of Cologne, Germany.
Crit Rev Oncol Hematol. 2016 Jul;103:10-21. doi: 10.1016/j.critrevonc.2016.04.002. Epub 2016 Apr 8.
With increasing numbers of adult female survivors of childhood cancers due to advances in early diagnosis and treatment, the issue of preserving the reproductive potential of prepubertal girls undergoing gonadotoxic treatments has gained greater attention.
According to PRISMA guidelines, a systematic review of the literature was performed for all relevant full-text articles published in PubMed in English throughout the past 15 years to explore the significant updates in preserving the reproductive potential of prepubertal girls with cancer.
The two established fertility preservation options, embryo freezing and egg freezing, cannot be offered routinely to prepubertal girls as these options necessitate prior ovarian stimulation and subsequent mature oocytes retrieval that are contraindicated or infeasible before puberty. Therefore, the most suitable fertility preservation options to prepubertal girls are (1) ovarian tissue freezing and autotransplantation, (2) in vitro maturation, and (3) ovarian protection techniques. In this review, we discuss in detail those options as well as their success rates, advantages, disadvantages and future directions. We also suggest a new integrated strategy to preserve the reproductive potential of prepubertal girls with cancer.
Although experimental, ovarian tissue slow freezing and orthotopic autotransplantation may be the most feasible option to preserve the reproductive potential of prepubertal girls with cancer. However, this technique has two major and serious disadvantages: (1) the risk of reintroducing malignant cells, and (2) the relatively short lifespan of ovarian tissue transplants. Several medical and ethical considerations should be taken into account before applying this technique to prepubertal girls with cancer.
由于早期诊断和治疗技术的进步,成年女性童年癌症幸存者的数量不断增加,因此,保护接受性腺毒性治疗的青春期前女孩的生殖潜力这一问题受到了更多关注。
根据PRISMA指南,对过去15年在PubMed上发表的所有相关英文全文文章进行了系统的文献综述,以探索保护患有癌症的青春期前女孩生殖潜力的重大进展。
两种已确立的生育力保存方法,即胚胎冷冻和卵子冷冻,不能常规应用于青春期前女孩,因为这些方法需要事先进行卵巢刺激并随后获取成熟卵母细胞,而这在青春期前是禁忌或不可行的。因此,对于青春期前女孩最合适的生育力保存方法是:(1)卵巢组织冷冻和自体移植,(2)体外成熟,以及(3)卵巢保护技术。在本综述中,我们详细讨论了这些方法及其成功率、优点、缺点和未来方向。我们还提出了一种新的综合策略来保护患有癌症的青春期前女孩的生殖潜力。
尽管是实验性的,但卵巢组织慢速冷冻和原位自体移植可能是保护患有癌症的青春期前女孩生殖潜力最可行的选择。然而,这项技术有两个主要且严重的缺点:(1)重新引入恶性细胞的风险,以及(2)卵巢组织移植的相对较短寿命。在将这项技术应用于患有癌症的青春期前女孩之前,应考虑若干医学和伦理因素。